Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.


Michael M., Groothoff J. W., Shasha-Lavsky H., Lieske J. C., Frishberg Y., Simkova E., ...Daha Fazla

American journal of kidney diseases : the official journal of the National Kidney Foundation, cilt.81, 2023 (SCI-Expanded) identifier identifier identifier